Vyome Holdings Inc (HIND) - צמיחת רווחים בשנה הנוכחית

Vyome Holdings Inc bases its success on a combination of antibacterial developments and weight management systems. Year-over-year EPS dynamics visualize this process, while the 86.70 metric confirms the current level. Price growth potential depends on the effectiveness of new topical agents; however, liquidity shortages and post-asset restructuring complexities create significant operational risks.
פילוחי מדדים מקיפים ואנליטיקה עבור Vyome Therapeutics (HIND)

This indicator determines the dynamics of net income per share, allowing for an assessment of the issuer's solvency by comparing current earnings with the debt load. The formula measures the annual growth rate of EPS, revealing hidden cash flow dips within the fundamental valuation. By analyzing the comparison of EPS with the same period last year, the investor can see the efficiency of clinical research outsourcing while Vyome Holdings Inc (HIND) maintains full control over its intellectual property.